Navigation Links
New BSI CE-Onsite Facilitates CE Marking Reviews for Device Manufacturers
Date:3/26/2009

RESTON, Va., March 26 /PRNewswire/ -- As a direct response from client feedback, BSI launches a new speed-to-market program, CE-Onsite FastTrack Review, for Class III medical devices needing European CE Marking Design Dossier Reviews. This new program will expedite the review process through live, onsite interaction, facilitating more efficient communication as well as the goal of completing the review in 45 working days.

The CE-Onsite has the same features of the CE-45 FastTrack Program, with one main difference: BSI Product Experts visit the manufacturer's premises to perform the review. As an industry norm, reviews are conducted via mail, email, fax and telephone and the process can take months. However, performing reviews onsite allows for a much faster timeline while still maintaining the same high quality. This face-to-face opportunity provides Product Experts accessibility to all relevant parties, from engineers to regulators, and supports dynamic communication, immediate access to documentation and in-person viewing of the new product.

This new premium program is not for everyone or every product. As with the CE-90 and CE-45 programs, some products such as medicinal, blood and animal tissue products, require the use of outside agencies and may not be eligible for CE-Onsite Review. In addition, while BSI's goal is to complete the review with either a positive or negative recommendation within 45 working days, the length of the review greatly depends on the degree to which the manufacturer is prepared. In order to make the review as effective as possible, clients should have a strong motivation to get their product to market and excellent documentation, and be well-organized and responsive to questions. Manufacturers utilizing the CE-Onsite have experienced numerous advantages including shorter launch times, patients gaining access to new technology sooner and quicker return on investment.

"The interact
'/>"/>

SOURCE BSI
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Brotman Medical Center Facilitates Restructuring Through Chapter 11 Filing
2. Optimal band imaging with endoscopy facilitates the diagnosis of depressed-type early gastric cancer
3. Interview by Internet Can Decrease Greatest End-of-Life Fears: It Facilitates Creating Effective Advance Directives, Living Wills
4. Misys Facilitates Masraf Al Rayans Expansion of Islamic Banking Operations
5. ACS Facilitates Emergency Prescription Assistance Program Now Activated in Southern Louisiana
6. TeleHealth Services TIGR(R) Interactive Patient Education System Facilitates Award-Winning Results at Northridge Hospital Medical Center
7. Chamberlain Group Surgical Training Model Facilitates New Treatment for Chronic Rhinosinusitis
8. The Integrated Benefits Institute Offers Largest Benchmarking Database in U.S. Spanning Disability and Workers Compensation Programs
9. BeneChills RhinoChill System Receives CE Marking for European Commercial Sale
10. ANSYS Expands HPC Benchmarking Program
11. Global Benchmarking Council Launches New Virtual Tour of Research & Networking Service
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2015)... (PRWEB) February 28, 2015 ... of outsourced sales, marketing and supply chain management ... BIOTA Botanicals, is bringing its award winning solutions ... BIOTA Botanicals’ products are specifically created to combat ... experts, BIOTA is committed to marrying science with ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 How ... Supportive? Strategic? , There are all kinds of ... To raise awareness of the advantages and applications ... PeopleKeys is launching a new product this spring ... better understand the connection between personality type, leadership, ...
(Date:2/28/2015)... Javon Bea Mercy Health System ... as stroke capable by the State of Illinois, enabling ... Mercy Harvard Hospital. , The hospital was required to ... to treat stroke according to national standards of care ... patients to bypass hospitals not designated as an Emergent ...
(Date:2/28/2015)... My Shiney Hiney® LLC., the renowned brand in ... Vegas, Nevada for the annual ASD Market Week tradeshow. ... consumer-goods tradeshows and My Shiney Hiney will be one of ... Hiney can be found at booth number C1663. , My ... personal hygiene brush and cleansing system exclusively created to clean ...
(Date:2/27/2015)... 2015 A new study published in ... men who cycle on a regular basis and prostate cancer. ... suggests that the more hours per week a man spends ... leading to an increased importance on prostate cancer screening methods. ... look more closely at patents’ risk factors for developing prostate ...
Breaking Medicine News(10 mins):Health News:BIOTA Botanicals Brings Thinning-Damaged Hair Solutions to the Hair Care Aisle at Walgreens 2Health News:BIOTA Botanicals Brings Thinning-Damaged Hair Solutions to the Hair Care Aisle at Walgreens 3Health News:PeopleKeys Launches The Leadership Report 2Health News:PeopleKeys Launches The Leadership Report 3Health News:Mercy Harvard Hospital Recognized as Leader in Stroke Care - Javon Bea 2Health News:My Shiney Hiney® to Participate in ASD Market Week 2015 2Health News:Study Finds That Cycling Increases Risk For Prostate Cancer 2Health News:Study Finds That Cycling Increases Risk For Prostate Cancer 3
... of the tissue culture variety of anti-rabies vaccine, West ... the restricted nerve tissue variety vaccine till the demand-supply ... Surjyakanta Mishra told reporters here today that the Centre ... years ago citing side-effects., ,"However, since the demand-supply ...
... had affected more than 2.85 lakh population in parts of Karnataka ... , ,As against 1.20 lakh cases reported till April this ... in June so far, Minister for Health R Ashok said while ... that the government has failed to take urgent steps to contain ...
... suggests that the belief of being watched makes people behave more honestly, ... team monitored people dropping money in a canteen ... people put nearly three times more money when a poster ... poster showing flowers. , The poster might have ...
... Allison, a University of Alabama biostatistician has compiled a report ... was assisted in this venture by 19 other scientists in ... looked at more than 100 studies on the reasons for ... reasons could be an answer ,* Inadequate sleep: ...
... harassment and violence have become a way of life in ... name of combating Maoist guerrillas, say child rights activists here. ... of 36 rights organisations, says it has been urging the ... security forces from all occupied schools but to no avail. ...
... be the combination of dry eyes and mouth//, which lasts ... dry, gritty or burning eyes, intermittent blurry vision, a dry ... glands. The parotids are a pair of salivary glands behind ... and symptoms may include dry skin or vaginal dryness in ...
Cached Medicine News:Health News:Girl Students Sexually Harassed by Security Forces in Nepal 2
(Date:2/27/2015)... , Feb. 27, 2015   Synageva BioPharma Corp. ... biopharmaceutical company developing therapeutic products for rare diseases, ... the European Organisation for Rare Diseases™ (EURORDIS™), The ... in observing Rare Disease Day. On ... organizations, industry, and other participants conduct special events ...
(Date:2/27/2015)... 2015  PTC Therapeutics, Inc. (NASDAQ: PTCT ... results for the fourth quarter and full year ended ... transformative year for PTC. We are now a growing ... therapies in the rare disease space," stated Stuart W. ... are proud to bring the first treatment for Duchenne ...
(Date:2/27/2015)... , Feb. 27, 2015  Uroplasty, Inc. (NASDAQ: ... and markets innovative proprietary products to treat voiding dysfunctions, ... Annual ROTH Conference on Tuesday, March 10, 2015. ... Reynolds , Chief Financial Officer, will present at 4:00 ... one at the conference at the Ritz Carlton in ...
Breaking Medicine Technology:Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 2Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 3Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 4Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 5Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 6PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 10PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 11Uroplasty to Participate in the 27th Annual ROTH Conference 2
... COCOA, Fla., March 22, 2011 GeNO LLC ... technology company, today announced commencement of  the PHiano ... Treatment of Pulmonary Hypertension in patients with Pulmonary ... Idiopathic Pulmonary Fibrosis (PH-IPF) using Inhaled NITROSYL™ nitric ...
... MADISON, Wis., March 22, 2011 ... two-year collaboration with Roche (SIX: RO, ROG; OTCQX: RHHBY) ... predictive tool for assessing the potential cardiotoxic effects of ... transitioning into a standard supply agreement.  Moving forward, iCell ...
Cached Medicine Technology:GeNO LLC Initiates Study of Inhaled NITROSYL™ Nitric Oxide in Idiopathic Pulmonary Fibrosis (PH-IPF) and Pulmonary Arterial Hypertension (PAH) Patients 2GeNO LLC Initiates Study of Inhaled NITROSYL™ Nitric Oxide in Idiopathic Pulmonary Fibrosis (PH-IPF) and Pulmonary Arterial Hypertension (PAH) Patients 3Cellular Dynamics International and Roche Transition Early Access Collaboration into a Standard Supply Agreement Ahead of Schedule 2
Endoscopes are also available in fully autoclavable models in 1.8, 2.7, 4.0. 5.0 and 10.0 mm diameters. Manufactured with precise swiss lenses. Built-in temperature measuring device to exactly determ...
Cottle Tenaculum Skin Hook. 5 1/2" small, shallow curve....
Goldman single hook....
Needle tip electrode, davol advantage electrosurgical attachments, 33cm (with extendible outer sheath), non-sterile. These products are supplied non-sterile and must be sterilized before use. Reusabl...
Medicine Products: